drugset / Trial / NCT00079105

A Phase II Study VEPEMB In Patients With Hodgkin's Lymphoma Aged ≥ 60 Years

NCT00079105

Phase 2 Completed 175 enrolled Newcastle-upon-Tyne Hospitals NHS Trust
RandomizedParallel-groupOpen-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy, such as vinblastine, cyclophosphamide, procarbazine, prednisolone, etoposide, mitoxantrone, and bleomycin, work in different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one chemotherapy drug may kill more cancer cells. PURPOSE: This phase II trial is studying how well combination chemotherapy works in treating older patients with previously untreated Hodgkin's lymphoma.

Timeline

Start
2004-01
Primary completion
2010-12
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bleomycin Unknown Intravenous
Comparator Cyclophosphamide Other / unclassified Intravenous
Comparator Etoposide Small molecule Oral
Comparator Mitoxantrone Small molecule Intravenous
Comparator Prednisolone Other / unclassified Oral
Comparator Vinblastine Small molecule Intravenous
Comparator procarbazine Small molecule Oral

Indications